Traws Historical Income Statement
| TRAW Stock | 4.58 0.16 3.38% |
Historical analysis of Traws Pharma income statement accounts such as Other Operating Expenses of 17 M, Research Development of 10 M, Total Operating Expenses of 17 M or Total Other Income Expense Net of 1.4 M can show how well Traws Pharma performed in making a profits. Evaluating Traws Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Traws Pharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Traws Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Traws Pharma is a good buy for the upcoming year.
Traws |
About Traws Income Statement Analysis
Traws Pharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Traws Pharma shareholders. The income statement also shows Traws investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Traws Pharma Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Traws Pharma generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Traws Pharma minus its cost of goods sold. It is profit before Traws Pharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Traws Pharma. It is also known as Traws Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Traws Pharma whose combined shares represent less than 50% of the total outstanding shares issued by Traws Pharma have a minority interest in Traws Pharma.Most accounts from Traws Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Total Other Income Expense Net is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 9.7 M in 2024, whereas Total Revenue is likely to drop slightly above 193.2 K in 2024.
| 2020 | 2023 | 2024 (projected) | Total Revenue | 231K | 203.4K | 193.2K | Depreciation And Amortization | 13K | 16K | 15.6K |
Traws Pharma income statement Correlations
Click cells to compare fundamentals
Traws Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.